Sensei Biotherapeutics
SNSE
SNSE
39 hedge funds and large institutions have $7.06M invested in Sensei Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
-3
Holders Change %
-7.14%
% of All Funds
0.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
16
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$1.64M |
| 2 |
NM
2
Newtyn Management
New York
|
$942K |
| 3 |
3
Renaissance Technologies
New York
|
$561K |
| 4 |
E
4
Ergoteles
New York
|
$212K |
| 5 |
5
Millennium Management
New York
|
$304K |
